Menu
Currency
GWAS Study

A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3.

Kaplan RC, Petersen AK, Chen MH et al.

21216879 PubMed ID
GWAS Study Type
10280 Participants
35 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

KR
Kaplan RC
PA
Petersen AK
CM
Chen MH
TA
Teumer A
GN
Glazer NL
DA
Döring A
LC
Lam CS
FN
Friedrich N
NA
Newman A
MM
Müller M
YQ
Yang Q
HG
Homuth G
CA
Cappola A
KN
Klopp N
SH
Smith H
EF
Ernst F
PB
Psaty BM
WH
Wichmann HE
SD
Sawyer DB
BR
Biffar R
RJ
Rotter JI
GC
Gieger C
SL
Sullivan LS
VH
Völzke H
RK
Rice K
SA
Spyroglou A
KH
Kroemer HK
IC
Ida Chen YD
MJ
Manolopoulou J
NM
Nauck M
SH
Strickler HD
GM
Goodarzi MO
RM
Reincke M
PM
Pollak MN
BM
Bidlingmaier M
VR
Vasan RS
WH
Wallaschofski H
Chapter II

Abstract

Summary of the research findings

Insulin-like growth factor-I (IGF-I) and insulin-like growth factor-binding protein-3 (IGFBP-3) are involved in cell replication, proliferation, differentiation, protein synthesis, carbohydrate homeostasis and bone metabolism. Circulating IGF-I and IGFBP-3 concentrations predict anthropometric traits and risk of cancer and cardiovascular disease. In a genome-wide association study of 10 280 middle-aged and older men and women from four community-based cohort studies, we confirmed a known association of single nucleotide polymorphisms in the IGFBP3 gene region on chromosome 7p12.3 with IGFBP-3 concentrations using a significance threshold of P < 5 × 10(-8) (P = 3.3 × 10(-101)). Furthermore, the same IGFBP3 gene locus (e.g. rs11977526) that was associated with IGFBP-3 concentrations was also associated with the opposite direction of effect, with IGF-I concentration after adjustment for IGFBP-3 concentration (P = 1.9 × 10(-26)). A novel and independent locus on chromosome 7p12.3 (rs700752) had genome-wide significant associations with higher IGFBP-3 (P = 4.4 × 10(-21)) and higher IGF-I (P = 4.9 × 10(-9)) concentrations; when the two measurements were adjusted for one another, the IGF-I association was attenuated but the IGFBP-3 association was not. Two additional loci demonstrated genome-wide significant associations with IGFBP-3 concentration (rs1065656, chromosome 16p13.3, P = 1.2 × 10(-11), IGFALS, a confirmatory finding; and rs4234798, chromosome 4p16.1, P = 4.5 × 10(-10), SORCS2, a novel finding). Together, the four genome-wide significant loci explained 6.5% of the population variation in IGFBP-3 concentration. Furthermore, we observed a borderline statistically significant association between IGF-I concentration and FOXO3 (rs2153960, chromosome 6q21, P = 5.1 × 10(-7)), a locus associated with longevity. These genetic loci deserve further investigation to elucidate the biological basis for the observed associations and clarify their possible role in IGF-mediated regulation of cell growth and metabolism.

10,280 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

10280
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S., Germany
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.